High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
Published Online: 2022-09-07
Journal: Nature CommunicationsLoading...
Authors: Abel Gonzalez-Perez•Aleix Prat•Alejandra Bruna•Alicia García-Sanz•Analía Azaro•Andreu Òdena•Carlos Caldas•Chandra S. Verma•Cristina Saura•Cristina Viaplana•Fara Brasó-Maristany•Faye Su•Guillermo Villacampa•Javier Hernández•Joaquín Arribas•Judit Grueso•Kui Lin•Laia Monserrat•Leonardo Mina•Mafalda Oliveira•Maria Teresa Herrera-Abreu•Marta Capelán•Marta Guzmán•Marta Palafox•Maurizio Scaltriti•Meritxell Bellet•Monica Arnedos•Mònica Sánchez-Guixé•Nicholas C. Turner•Nuria Lopez-Bigas•Nusaibah Ibrahimi•Olga Rodríguez•Paolo Nuciforo•Robert B. Clarke•Rodrigo Dienstmann•Srinivasaraghavan Kannan•Stefan Michiels•Violeta Serra
